AACE Rare Endocrine Disease Series is pleased to present Recognizing and Treating X-Linked Hypophosphatemia a Lifelong Progressive Disease, a webinar designed to help clinicians create a path to diagnosis when encountering a patient with x-linked hypophosphatemia.
This disease was chosen due to its rarity, symptom complexity, and need for improved diagnostic and management strategies. The webinar will provide clinicians with the latest evidence-based guidelines, algorithms, consensus statements, and educational resources for diagnosing, managing, and treating these conditions. By highlighting the latest research and clinical advances, AACE aims to increase clinicians’ awareness, knowledge, and competence, ultimately improving the quality of care and outcomes for patients with this rare endocrine disease.
Recognizing and Treating X-Linked Hypophosphatemia a Lifelong Progressive Disease webinar will be held on Friday, October 4th at 1:00PM EDT.
Upon completion of the program, participants will be able to:
Planner Disclosures
Ranjodh Gill, MD, FACE – No relationships to disclose
Basma Abdulhadi, MD – No relationships to disclose
Amy Ogunsunlade: No relationships to disclose
Speaker Disclosures
Mike Lewiecki, MD, FACE – Angitia: Research Funding, Consultant; Amgen: Consultant, Speakers’ Bureau; Radius: Consultant, Speakers’ Bureau; Kyowa Kirin: Consulant, Speakers’ Bureau; Ascendis: Consultant, Speakers’ Bureau